跳至主要内容
临床试验/IRCT201305213930N25
IRCT201305213930N25已完成3 期

A head to head comparison of aripiprazole versus olanzaoine as adjvants to lithium for treating manic or mixed episodes in bipolar I disorder

Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 65 years(—)
性别
All

入选标准

  • patients from both gender aged 16 to 65 years old with bipolar mood disorder-type I- manic phase.
  • Exclusion criteria: sever uncontrolled medical conditions such as hypothyroidism; positive history of allergy to one of the medications.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shiraz University of Medical Sciences

相似试验